David Yaeger

A ligand-reversible dimerization system for controlling protein–protein interactions

Carl T. Rollins, Victor M. Rivera, Derek N. Woolfson et al. · Proceedings of the National Academy of Sciences · 2000 · 189 citations · Full text

Synthesis and activity of bivalent FKBP12 ligands for the regulated dimerization of proteins

Terence P. Keenan, David Yaeger, Nancy L. Courage et al. · Bioorganic & Medicinal Chemistry · 1998 · 62 citations

Protein Chemistry, Protein Function, Biochemistry +8

(±)-<i>trans</i>-2-[3-Methoxy-4-(4-chlorophenylthioethoxy)-5-(<i>N</i>-methyl-<i>N</i>- hydroxyureidyl)methylphenyl]-5-(3,4,5-trimethoxyphenyl)tetrahydrofuran (CMI-392), a Potent Dual 5-Lipoxygenase Inhibitor and Platelet-Activating Factor Receptor Antagonist

Xiong Cai, Ralph T. Scannell, David Yaeger et al. · Journal of Medicinal Chemistry · 1998 · 14 citations · Full text

Molecular Pharmacology, Medicinal Chemistry, Pharmacological Study +14

Synthesis of chiral nonracemic 4-trans-substituted pipecolic acid derivatives

Terence P. Keenan, David Yaeger, Dennis A. Holt · Tetrahedron Asymmetry · 1999 · 13 citations

Organic Chemistry, Chemistry, Asymmetric Catalysis +2